Company: BFRG
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023560
Chunk: 84

Company: BullFrog AI Holdings, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 2
Chunk 84
---
22

PART
II. OTHER INFORMATION

Item
1 Legal Proceedings.

To
our best knowledge, we are currently not a party to any legal proceedings that, individually or in the aggregate, are deemed to be material
to our financial condition or results of operations.

Item
1A Risk Factors.

Smaller
reporting companies are not required to provide the information required by this item.

Item
2 Unregistered Sales of Equity Securities and Use of Proceeds.

There
were no unregistered sales of equity securities during the six months ended June 30, 2025.

Item
3 Defaults Upon Senior Securities.

None.

Item
4 Mine Safety Disclosures.

Not
applicable.

Item
5 Other Information. 

(c)
Insider Trading Arrangements

During
the quarter ended June 30, 2025, none of the Company’s directors or executive officers adopted, modified or terminated any contract,
instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions
of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement”. As previously disclosed, in June 2023, Vininder Singh, the
Chief Executive Officer and a Director of the Company, entered into a 10b5-1 sales plan (the “10b-5 Sales Plan”) intended
to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The 10b5 Sales Plan provides for the sale of up to 1,000,000
shares of common stock and will remain in effect until the earlier of (1) August 31, 2025; or (2) the date on which an aggregate of 1,000,000
shares of common stock have been sold under the 10b5 Sales Plan. Pursuant to the 10b5 Sales Plan, 50,000 shares were sold under the plan
in September 2023, 100,000 shares were sold under the plan in the first quarter of 2024, and 50,000 shares were sold under the plan in
each of the second, third, and fourth quarters of 2024, and in each of the first and second quarters of 2025.

23

Item
6. EXHIBITS

    Exhibit
    No.
     
    Description
  
    1.1
     
    At-The-Market Sales Agreement, dated April 25